Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
vaniprevir (MK-7009)
print preview
bookmark
share with colleague
General Information
Company
Merck & Co. Inc.
Description
HCV NS3/4A protease complex inhibitor
Molecular Target
HCV NS3/4A protease complex
Mechanism of Action
Viral protease inhibitor
Latest Stage of Development
Phase III
Indication
Hepatitis C virus (HCV)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information